Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01849120 · ClinicalTrials.gov registry record

NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
35
Enrollment target

NCT01849120: Completed study, sponsored by Mayo Clinic.

NCT01849120 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01849120 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
35 participants
Enrollment target

Study Summary

Neonates and infants that have cardiac surgery with cardiopulmonary bypass (CPB) for congenital heart disease are at great risk for experiencing life-threatening low cardiac output syndrome (LCOS) in the first 24 hours after surgery. The poor perfusion and inadequate oxygen delivery that occurs may result in multiple organ failure and death. It is LCOS that is responsible for the majority of early postoperative deaths in this population of neonates and infants. Improved pediatric probes placed in peripheral locations using near infrared spectroscopy (NIRS) may permit continuous monitoring of venous saturations reflecting overall perfusion and oxygen balance in the tissues. Following parental or guardian consent, 30 neonates and infants scheduled to undergo surgery for congenital heart disease will be enrolled. At the end of surgery, four EQUANOX Advance 8004CB probes will be placed on the flank, lower extremities and the forehead. Continuous NIRS saturations will be monitored and stored for analysis. Point of care (POC) lactates will be obtained after admission to the intensive care unit (ICU) every 2 hours for the first 24 hours postoperatively, then once at 48 hours. The association between NIRS oxygen saturation and POC lactate values will be assessed using mixed linear models taking into account the repeated measures design. Exploratory analyses will be performed to assess whether NIRS oxygen saturation is associated with outcomes such as days in ICU, adverse events and mortality. The ability to use noninvasive, continuous monitoring for overall perfusion and cardiac output will allow better and earlier therapy for neonates and infants following cardiac surgery.

Interventions

  • DEVICE EQUANOX Advance 8004CB sensor

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2013-05
Est. Completion 2015-09

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01849120

The ClinicalTrials.gov registry entry for NCT01849120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EQUANOX Advance 8004CB sensor is the first listed.

NCT01849120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01849120 about?

NCT01849120 is a clinical study titled "NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery". Neonates and infants that have cardiac surgery with cardiopulmonary bypass (CPB) for congenital heart disease are at great risk for experiencing life-threatening low cardiac output syndrome (LCOS) in the first 24 hours after surgery. The poor perfusion and inadequate oxygen delivery that occurs may ...

What is the current status of trial NCT01849120?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2013-05. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01849120?

The interventions under investigation include: EQUANOX Advance 8004CB sensor (DEVICE).

Who is sponsoring clinical trial NCT01849120?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.